Vaxcyte reported net income of -$285.01M for the quarter ended Jun 2026. This income statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 52.59M | 53.03M | 56.50M | 58.62M | 60.57M | 64.88M | 80.64M | 93.81M | 95.10M | 95.36M | 108.76M | 110.58M | 124.43M | 124.89M | 128.94M | 129.82M | 130.03M | 131.06M | 144.31M | 144.79M | ||||||||||
| Operating items | ||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 20.43M | 23.07M | 31.68M | 38.47M | 47.68M | 51.63M | 58.08M | 72.69M | 97.42M | 104.15M | 94.59M | 131.51M | 116.94M | 133.61M | 148.13M | 194.18M | 209.93M | 242.06M | 312.78M | 267.85M | ||||||||||
| Selling, General & AdministrativeSG&A | 6.52M | 6.77M | 7.54M | 9.42M | 10.90M | 11.95M | 13.11M | 14.46M | 15.61M | 17.53M | 19.89M | 21.47M | 22.99M | 28.55M | 32.66M | 32.04M | 32.45M | 32.22M | 33.07M | 34.92M | ||||||||||
| Other Operating ExpensesOther Opex | 23.00M | 75.00M | ||||||||||||||||||||||||||||
| Operating ExpensesOpex | 26.95M | 29.85M | 39.22M | 47.89M | 58.58M | 86.57M | 71.19M | 87.15M | 113.03M | 196.68M | 114.47M | 152.98M | 139.92M | 162.17M | 180.79M | 226.22M | 242.38M | 274.28M | 345.85M | 302.78M | ||||||||||
| Operating IncomeOp. Inc | -26.95M | -29.85M | -39.22M | -47.89M | -58.58M | -86.57M | -71.19M | -87.15M | -113.03M | -196.68M | -114.47M | -152.98M | -139.92M | -162.17M | -180.79M | -226.22M | -242.38M | -274.28M | -345.85M | -302.78M | ||||||||||
| EBIT | -26.95M | -29.85M | -39.22M | -47.89M | -58.58M | -86.57M | -71.19M | -87.15M | -113.03M | -196.68M | -114.47M | -152.98M | -139.92M | -162.17M | -180.79M | -226.22M | -242.38M | -274.28M | -345.85M | -302.78M | ||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.00M | |||||||||||||||||||||||||||||
| Non Operating Investment Income | 0.02M | 0.03M | 0.00M | |||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.09M | 0.10M | -0.59M | 0.40M | 1.19M | 6.63M | 10.39M | 16.45M | 18.50M | 17.57M | 21.67M | 23.81M | 28.06M | 36.46M | 32.94M | 31.07M | 29.26M | 26.45M | 26.61M | 25.75M | ||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.34M | 1.28M | 0.23M | -1.73M | -0.69M | 11.25M | 10.73M | 18.81M | 20.36M | -47.03M | -2.21M | 0.47M | 8.74M | -11.37M | 7.14M | 28.57M | 0.29M | 1.32M | -1.38M | -7.28M | ||||||||||
| Non Operating IncomeNon Op. Inc. | 19.45M | 24.28M | 36.80M | 25.09M | 40.08M | 59.65M | 29.55M | 27.78M | 25.23M | 18.48M | ||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||
| EBT | -26.86M | -29.75M | -39.81M | -47.49M | -57.39M | -79.94M | -60.80M | -70.70M | -94.53M | -179.11M | -92.81M | -129.17M | -111.87M | -125.71M | -147.86M | -195.15M | -213.12M | -247.83M | -319.24M | -277.02M | ||||||||||
| Profit After TaxPAT | -26.62M | -28.79M | -38.99M | -48.53M | -57.92M | -77.75M | -60.46M | -68.34M | -92.66M | -178.87M | -95.02M | -128.70M | -104.80M | -141.09M | -140.72M | -168.14M | -212.83M | -246.51M | -320.62M | -285.01M | ||||||||||
| Income from Continuing OperationsIncome (Continuing) | -26.86M | -29.75M | -39.81M | -47.49M | -57.39M | -79.94M | -60.80M | -70.70M | -94.53M | -179.11M | -92.81M | -129.17M | -111.87M | -125.71M | -147.86M | -195.15M | -213.12M | -247.83M | -319.24M | -277.02M | ||||||||||
| Consolidated Net IncomeConsol Net Inc. | -26.86M | -29.75M | -39.81M | -47.49M | -57.39M | -79.94M | -60.80M | -70.70M | -94.53M | -179.11M | -92.81M | -129.17M | -111.87M | -125.71M | -147.86M | -195.15M | -213.12M | -247.83M | -319.24M | -277.02M | ||||||||||
| Income towards Parent CompanyParent Net Inc | -26.86M | -29.75M | -39.81M | -47.49M | -57.39M | -79.94M | -60.80M | -70.70M | -94.53M | -179.11M | -92.81M | -129.17M | -111.87M | -125.71M | -147.86M | -195.15M | -213.12M | -247.83M | -319.24M | -277.02M | ||||||||||
| Net Income towards Common StockholdersNet Income | -26.61M | -28.56M | -38.99M | -48.53M | -57.92M | -78.05M | -60.46M | -68.34M | 92.66M | -623.73M | -92.81M | -129.17M | -111.87M | -125.71M | -147.86M | -195.15M | -213.12M | -247.83M | -319.24M | -277.02M | ||||||||||
| Additional items | ||||||||||||||||||||||||||||||
| EPS (Basic) | -0.51 | -0.55 | -0.68 | -0.80 | -0.93 | -1.20 | -0.70 | -0.70 | 0.91 | -6.42 | -0.83 | -1.10 | -0.90 | -1.03 | -1.09 | -1.43 | -1.56 | -1.82 | -2.29 | -1.92 | ||||||||||
| EPS (Diluted) | -0.51 | -0.55 | -0.68 | -0.80 | -0.93 | -1.20 | -0.70 | -0.70 | 0.91 | -6.42 | -0.83 | -1.10 | -0.90 | -1.03 | -1.09 | -1.43 | -1.56 | -1.82 | -2.29 | -1.92 | ||||||||||
| Shares Outstanding | 52.19M | 51.92M | 57.55M | 60.82M | 61.99M | 64.88M | 86.21M | 98.06M | 101.67M | 97.16M | 111.69M | 117.26M | 123.69M | 122.00M | 135.69M | 136.03M | 136.20M | 136.09M | 139.51M | 144.49M | ||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 52.19M | 51.92M | 57.55M | 60.82M | 61.99M | 64.88M | 86.21M | 98.06M | 101.67M | 97.16M | 111.69M | 117.26M | 123.69M | 122.00M | 135.69M | 136.03M | 136.20M | 136.09M | 139.51M | 144.49M | ||||||||||
| EBITDA | -26.95M | -29.85M | -39.22M | -47.89M | -58.58M | -86.57M | -71.19M | -87.15M | -113.03M | -196.68M | -114.47M | -152.98M | -139.92M | -162.17M | -180.79M | -226.22M | -242.38M | -274.28M | -345.85M | -302.78M | ||||||||||
| Interest ExpensesInt Expense | 0.00M |